Cost-Effectiveness of AI-Enabled Electrocardiography for Screening MASLD-Associated Advanced Chronic Liver Disease in the US Population
Basile Njei, Dam Nsoh, Christian Akem Dimala, Yussif Issaka et autres
0 citationsDigestive Diseases and Sciences
Yussif Issaka
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
72Publications signalées
31Citations signalées
5Affiliations récentes
Institutions déclarées
Domaines associés
Diabetes Treatment and ManagementLiver Disease Diagnosis and TreatmentHeart Failure Treatment and ManagementLiver Disease and TransplantationLiver Diseases and Immunity
Publications récentes
Optimal Timing of GLP-1 Receptor Agonist Initiation in Patients with Obesity Eligible for Metabolic Bariatric Surgery
Guy Nguefang, Sarpong Boateng, Yussif Issaka, Edgar Luna Landa et autres
0 citationsObesity Surgery
Persistent gaps in management and risk factor control among patients with atherosclerotic cardiovascular disease: All of us research program
Yakubu Bene‐Alhasan, Soad Al Osta, Yussif Issaka, Isaac Acquah et autres
0 citationsAtherosclerosis
Persistent Gaps in Management and Risk Factor Control Among Patients with Atherosclerotic Cardiovascular Disease: All of Us Research Program
Yakubu Bene‐Alhasan, Soad Al Osta, Yussif Issaka, Isaac Acquah et autres
0 citationsJournal of clinical lipidology
Effect of coded steatotic liver disease on outcomes of percutaneous coronary intervention in non-diabetic adults: insights from a multicenter real-world cohort
Yussif Issaka, Mohammad Maraqah, Didien Meyahnwi, Kwame Adjei-Sefah et autres
0 citationsBMC Cardiovascular Disorders
Additional file 1 of Effect of coded steatotic liver disease on outcomes of percutaneous coronary intervention in non-diabetic adults: insights from a multicenter real-world cohort
Yussif Issaka, Mohammad Maraqah, Didien Meyahnwi, Kwame Adjei-Sefah et autres
0 citationsFigshare
Additional file 1 of Effect of coded steatotic liver disease on outcomes of percutaneous coronary intervention in non-diabetic adults: insights from a multicenter real-world cohort
Yussif Issaka, Mohammad Maraqah, Didien Meyahnwi, Kwame Adjei-Sefah et autres
0 citationsFigshare
Tu1654 CARDIOMETABOLIC AND RENAL OUTCOMES OF GLP-1 RECEPTOR AGONISTS VS SGLT2 INHIBITORS IN IBD WITH OBESITY OR MASLD: A REAL-WORLD PROPENSITY-MATCHED STUDY
Yussif Issaka, Guy Nguefang, Elvis Eze, Joël Gabin Konlack Mekontso et autres
0 citationsGastrointestinal Endoscopy
496 IMPACT OF GLP-1 RECEPTOR AGONISTS ON CLINICAL OUTCOMES IN ADULTS WITH PRIMARY BILIARY CHOLANGITIS
Guy Nguefang, Sarpong Boateng, Yussif Issaka, Joël Gabin Konlack Mekontso et autres
0 citationsGastroenterology
Tu1790 OPTIMAL TIMING FOR GLP-1 RECEPTOR AGONIST INITIATION IN OBESE PATIENTS UNDERGOING METABOLIC BARIATRIC SURGERY
Guy Nguefang, Sarpong Boateng, Yussif Issaka, Edgar M. Luna Landa et autres
0 citationsGastrointestinal Endoscopy
1082 IMPACT OF GLP-1 RECEPTOR AGONIST USE IN ADULTS WITH SICKLE CELL DISEASE AND TYPE 2 DIABETES: A REAL-WORLD COHORT ANALYSIS
Guy Nguefang, Yussif Issaka, Sarpong Boateng, Edgar M. Luna Landa et autres
0 citationsGastrointestinal Endoscopy
494 IMPACT OF GLP-1 RECEPTOR AGONISTS ON CLINICAL OUTCOMES IN AUTOIMMUNE HEPATITIS: A PROPENSITY SCORE-MATCHED COHORT STUDY
Guy Nguefang, Yussif Issaka, Tracy Chukwu, Edgar M. Luna Landa et autres
0 citationsGastroenterology
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.